Shucai Zhang Selected Research

Shucai Zhang Research Topics

Disease

67	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 06/2004
24	Neoplasms (Cancer) 02/2024 - 08/2005
20	Lung Neoplasms (Lung Cancer) 01/2023 - 02/2002
16	Adenocarcinoma of Lung 12/2022 - 02/2013
9	Disease Progression 02/2024 - 08/2011
7	Neoplasm Metastasis (Metastasis) 12/2022 - 01/2016
6	Exanthema (Rash) 01/2020 - 08/2011
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019 - 04/2007
5	Brain Neoplasms (Brain Tumor) 01/2023 - 08/2016
4	Adenocarcinoma 11/2018 - 02/2002
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2022 - 01/2015
3	Infections 01/2021 - 05/2012
3	Diarrhea 01/2016 - 05/2014
3	Nausea 01/2016 - 08/2005
2	Neutropenia 01/2016 - 08/2011
2	Vomiting 03/2011 - 08/2005
1	Choristoma (Ectopic Tissue) 02/2024
1	Endometriosis 02/2024
1	Pain (Aches) 01/2022
1	Rupture 01/2021
1	Pericardial Effusion 01/2021
1	Pulmonary Hypertension 01/2021
1	Hypothyroidism 06/2019
1	Circulating Neoplastic Cells 04/2019

Drug/Important Bio-Agent (IBA)

22	ErbB Receptors (EGF Receptor)IBA 11/2023 - 02/2013
17	Tyrosine Kinase InhibitorsIBA 11/2023 - 08/2011
12	Anaplastic Lymphoma KinaseIBA 02/2024 - 12/2013
12	icotinibIBA 01/2020 - 05/2013
9	CrizotinibIBA 02/2024 - 01/2014
8	Cisplatin (Platino)FDA LinkGeneric 10/2012 - 06/2004
7	PlatinumIBA 01/2020 - 06/2004
6	Proteins (Proteins, Gene)FDA Link 02/2024 - 07/2010
6	Gefitinib (Iressa)FDA Link 11/2022 - 05/2012
5	osimertinibIBA 11/2023 - 08/2018
4	Carboplatin (JM8)FDA LinkGeneric 01/2024 - 06/2004
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 06/2004
4	aflutinibIBA 01/2023 - 01/2021
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
4	Alanine Transaminase (SGPT)IBA 01/2021 - 08/2011
4	Circulating Tumor DNAIBA 01/2021 - 01/2018
3	ensartinibIBA 02/2024 - 01/2020
3	AntigensIBA 02/2024 - 02/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 11/2013
3	Tumor Biomarkers (Tumor Markers)IBA 10/2016 - 02/2002
2	Cell-Free Nucleic AcidsIBA 01/2023 - 01/2021
2	Docetaxel (Taxotere)FDA Link 12/2022 - 02/2008
2	NivolumabIBA 01/2022 - 06/2019
2	brigatinibIBA 12/2021 - 12/2014
2	B7-H1 AntigenIBA 02/2021 - 06/2019
2	Therapeutic UsesIBA 02/2021 - 11/2015
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2020
2	Gemcitabine FDA Link 10/2012 - 08/2011
2	Carcinoembryonic AntigenIBA 05/2010 - 02/2002
2	Topotecan (Hycamtin)FDA LinkGeneric 02/2009 - 04/2007
2	Etoposide (VP 16)FDA LinkGeneric 02/2009 - 04/2007
2	EnzymesIBA 04/2004 - 02/2002
1	Aurora Kinase AIBA 02/2024
1	MLN 8237IBA 02/2024
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2024
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2024
1	Glucose (Dextrose)FDA LinkGeneric 02/2024
1	Estrogen Receptor betaIBA 02/2024
1	Estradiol (Delestrogen)FDA LinkGeneric 02/2024
1	matrigelIBA 02/2024
1	Estrogens (Estrogen)FDA Link 02/2024
1	CalponinsIBA 02/2024
1	penpulimabIBA 01/2024
1	Proprotein Convertase 9IBA 01/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2022
1	RNA (Ribonucleic Acid)IBA 12/2022
1	sintilimabIBA 12/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 12/2022
1	MicroRNAs (MicroRNA)IBA 12/2022
1	LigandsIBA 11/2022
1	Immune Checkpoint ProteinsIBA 11/2022
1	CateninsIBA 10/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Coloring Agents (Dyes)IBA 01/2021
1	Epithelial Cell Adhesion MoleculeIBA 01/2021
1	pyrotinibIBA 01/2020
1	carboxyamido-triazole (carboxyamidotriazole)IBA 01/2020
1	SteroidsIBA 01/2020
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2020
1	CytokinesIBA 12/2019
1	Messenger RNA (mRNA)IBA 12/2019
1	4-1BB Ligand (4 1BB Ligand)IBA 12/2019
1	Thyroxine (Levothyroxine)FDA LinkGeneric 06/2019
1	Immunoglobulin G (IgG)IBA 06/2019
1	Programmed Cell Death 1 ReceptorIBA 06/2019
1	GlycodelinIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	AutoantibodiesIBA 01/2018

Therapy/Procedure

33	Therapeutics 01/2023 - 08/2005
22	Drug Therapy (Chemotherapy) 01/2024 - 06/2004
4	Immunotherapy 01/2023 - 02/2021
3	Adjuvant Chemotherapy 01/2020 - 07/2010
1	Chemoradiotherapy 01/2024
1	Aftercare (After-Treatment) 05/2019
1	Punctures 11/2018